Follow Us On Social Media


Investigational BACE Inhibitor for Early Alzheimer’s Disease Moves to Phase 3 Trials

An investigational BACE inhibitor for the treatment of early Alzheimer’s disease is moving into Phase 3 trials, following confirmation from the FDA. Developed in a partn…

Once-Monthly Self-Administered Multiple Sclerosis Treatment Zinbryta Wins FDA Approval

The FDA has approved Zinbryta (daclizumab, Biogen/AbbVie), a once-monthly, self-administered, subcutaneous treatment for relapsing forms of multiple sclerosis (RMS). The …

NFL Player Donates to Studies Investigating Cannabinoids for Pain and CTE

NFL player Eugene Monroe has donated $80,000 to researchers at Johns Hopkins University and the University of Pennsylvania to examine the therapeutic potential of cannabinoid …

New Drug Class Established as Nuplazid Receives FDA Approval for Parkinson’s Disease Psychosis

The FDA has approved Nuplazid (pimavanserin) from Acadia Pharmaceuticals for the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis, whi…

AAN Unveils Overhauled Botulinum Toxin Guidelines

The American Academy of Neurology (AAN) has adopted new guidelines for the use of botulinum toxins for blepharospasm, cervical dystonia (CD), headache, and adult spasticity. T…

Featured NeuroTopic



physician counsel

Curated by Bryn Mawr Communications II and Endovascular Today

Open Payments Update: Will More Data + More Errors = More Physician Peril?

An early look at samples from the full 2014 Open Payments records suggests that physicians must be ready to review and dispute their records before they go public.

Open Payments Errors Could Put Physicians in a Bad Light

As the Open Payments website becomes more user-friendly, physicians must ensure their disclosures are accurate, or risk misinterpretation.


Contact Info

For advertising rates and opportunities:
Steve Farrell

For further information:
Alan Guralnick
Group Publisher
(484) 581-1832

About Practical Neurology

Launched in January 2002, Practical Neurology strives to enhance quality of care and improve the daily operation of neurology practices. Each month, our experts explain the real-world significance of recent advances in neurologic science and offer step-by-step advice on how to overcome the clinical and business challenges neurologists face. Our straightforward, how-to articles give neurologists tools they can put into practice right away.